1999
DOI: 10.1016/s0969-8043(98)00049-9
|View full text |Cite
|
Sign up to set email alerts
|

NHS–MAS3: a bifunctional chelator alternative to NHS–MAG3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 6 publications
0
13
0
Order By: Relevance
“…137 An interesting alternative approach for the use of radioactive PNA probes for therapeutic purposes deserves to be mentioned in this perspective. In the so-called "pretargeting using PNA" developed by Hnatowich et al, 120,127,128 a single-stranded PNA bound to a protein/antibody -which binds, for example, specifically to receptors over-expressed in cancer cells -is administered first into an animal or human, followed by admission of the complementary single-stranded radiolabeled PNA. This technique provides sufficient time for the protein-PNA conjugate to find its target and, for the excess of the construct, to be cleared from circulation and other tissues.…”
Section: Metal-containing Pnas As Radioactive Probesmentioning
confidence: 99%
“…137 An interesting alternative approach for the use of radioactive PNA probes for therapeutic purposes deserves to be mentioned in this perspective. In the so-called "pretargeting using PNA" developed by Hnatowich et al, 120,127,128 a single-stranded PNA bound to a protein/antibody -which binds, for example, specifically to receptors over-expressed in cancer cells -is administered first into an animal or human, followed by admission of the complementary single-stranded radiolabeled PNA. This technique provides sufficient time for the protein-PNA conjugate to find its target and, for the excess of the construct, to be cleared from circulation and other tissues.…”
Section: Metal-containing Pnas As Radioactive Probesmentioning
confidence: 99%
“…In such constructs, the role of the PNA is to direct the bioconjugate to a specific mRNA -a unique or a uniquely over-expressed mRNA in a diseased cell -while the function of the radioactive probe is to allow imaging to possibly provide information on cellular gene expression pattern and detect molecular changes at relatively early stages [13,42]. Hence, a number of in vivo biodistribution/hybridization studies of radiolabeled PNAs were undertaken [14,[17][18][19][20]22,[24][25][26][27][28][29][30][31][32][33]36,39,41,[43][44][45][46]. The majority of these reports involved the use of 99m Tc, probably due its ideal nuclear properties and the convenient availability from a commercial generator [47][48][49][50].…”
Section: Introductionmentioning
confidence: 99%
“…The first key to this strategy is the elimination of soluble exchange ligand in favor of a solid-phase source of carboxylic acids (Chelex 100 resin). As described in detail earlier, only 8 min is required to fully load (99% radiochemical yield) a 99m Tc chelator, such as MAS 3 (9), with 99m Tc (Fig. 2C).…”
Section: Solid-phase Prelabeling For Preparation Of 99m Tc-mas 3 Conjmentioning
confidence: 96%